Abiopharma

New Form S-1MEF - MetaVia Inc. Filed: 2026-01-15 AccNo: 0001104659-26-003908 Size: 269 KB

New Form 424B5 - AlphaTON Capital Corp Filed: 2026-01-15 AccNo: 0001171843-26-000276 Size: 501 KB

New Form SCHEDULE 13D/A - ORASURE TECHNOLOGIES INC Filed: 2026-01-15 AccNo: 0000902664-26-000236 Size: 9 KB

New Form DFAN14A - ORASURE TECHNOLOGIES INC Filed: 2026-01-15 AccNo: 0000902664-26-000237 Size: 295 KB

(19% Negative) ImmunityBio Inc (IBRX) Announces Delay in million Trials for situ (NMIBC CIS) Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations

(90% Positive) Ocugen Inc. (OCGN) Announces Clinical Development Update

Neufeld Leah R 🟢 acquired 2.6K shares of Immuneering Corp (IMRX) at $4.15 Transaction Date: Jan 13, 2026 | Filing ID: 000010

Myles David C. 🟡 adjusted position in 110.0K shares (2 derivative) of Olema Pharmaceuticals, Inc. (OLMA) at $28.99 ($4.1M) Transaction Date: Jan 12, 2026 | Filing ID: 000003

Director Lefkowitz Steven W 🟡 adjusted position in 0 shares (1 derivative) of CorMedix Inc. (CRMD) at $5.63 Transaction Date: Jan 12, 2026 | Filing ID: 004470

New Form SCHEDULE 13D/A - Atara Biotherapeutics, Inc. Filed: 2026-01-14 AccNo: 0001193125-26-013362 Size: 17 KB